|
CABOMETYX 20 mg filmom obalené tablety
tbl flm (fľ.HDPE) 1x30 ks
|
|
HLL01EX07 - Kabozantinib
|
TBL FLM |
Ipsen Pharma (FRA) |
Ipsen Pharma (FRA)
|
1412C |
10/2020 |
Nie
|
zobraziť
|
|
CABOMETYX 40 mg filmom obalené tablety
tbl flm (fľ.HDPE) 1x30 ks
|
|
HLL01EX07 - Kabozantinib
|
TBL FLM |
Ipsen Pharma (FRA) |
Ipsen Pharma (FRA)
|
1414C |
3/2020 |
Nie
|
zobraziť
|
|
CABOMETYX 60 mg filmom obalené tablety
tbl flm (fľ.HDPE) 1x30 ks
|
|
HLL01EX07 - Kabozantinib
|
TBL FLM |
Ipsen Pharma (FRA) |
Ipsen Pharma (FRA)
|
1416C |
3/2019 |
Nie
|
zobraziť
|
|
Caprelsa 100 mg filmom obalené tablety
tbl flm (blis.PVC/PVDC/Al) 1x30 ks
|
|
HLL01EX04 - Vandetanib
|
TBL FLM |
Sanofi B.V. (NLD) |
Swixx Biopharma s. r. o. (SVK)
|
32668 |
8/2016 |
Áno
|
zobraziť
|
|
Caprelsa 300 mg filmom obalené tablety
tbl flm (blis.PVC/PVDC/Al) 1x30 ks
|
|
HLL01EX04 - Vandetanib
|
TBL FLM |
Sanofi B.V. (NLD) |
Swixx Biopharma s. r. o. (SVK)
|
32669 |
4/2016 |
Áno
|
zobraziť
|
|
COMETRIQ 20 mg, COMETRIQ 80 mg tvrdé kapsuly
cps dur 84x20 mg + 28x80 mg, 1x1 set
|
|
HLL01EX07 - Kabozantinib
|
CPS DUR |
Ipsen Pharma (FRA) |
Ipsen Pharma (FRA)
|
1303B |
4/2015 |
Áno
|
zobraziť
|
|
Klertis 12,5 mg
cps dur (blis.PVC/Aclar/Al) 1x28 ks
|
|
HLL01EX01 - Sunitinib
|
CPS DUR |
EGIS Pharmaceuticals PLC (HUN) |
EGIS SLOVAKIA spol. s r.o. (SVK)
|
7498D |
1/2022 |
Áno
|
zobraziť
|
|
Klertis 25 mg
cps dur (blis.PVC/Aclar/Al) 1x28 ks
|
|
HLL01EX01 - Sunitinib
|
CPS DUR |
EGIS Pharmaceuticals PLC (HUN) |
EGIS SLOVAKIA spol. s r.o. (SVK)
|
7500D |
1/2022 |
Áno
|
zobraziť
|
|
Klertis 50 mg
cps dur (blis.PVC/Aclar/Al) 1x28 ks
|
|
HLL01EX01 - Sunitinib
|
CPS DUR |
EGIS Pharmaceuticals PLC (HUN) |
EGIS SLOVAKIA spol. s r.o. (SVK)
|
7502D |
1/2022 |
Áno
|
zobraziť
|
|
LENVIMA 10 mg
cps dur 10 mg (blis.PA/Al/PVC/Al) 1x30 ks
|
|
HLL01EX08 - Lenvatinib
|
CPS DUR |
Eisai GmbH (DEU) |
Eisai GmbH (DEU)
|
4841B |
11/2015 |
Nie
|
zobraziť
|
|
LENVIMA 4 mg
cps dur 4 mg (blis.PA/Al/PVC/Al) 1x30 ks
|
|
HLL01EX08 - Lenvatinib
|
CPS DUR |
Eisai GmbH (DEU) |
Eisai GmbH (DEU)
|
4840B |
11/2015 |
Áno
|
zobraziť
|
|
Nexavar 200 mg
tbl flm (blis.PP/Al) 1x112 ks
|
|
HLL01EX02 - Sorafenib
|
TBL FLM |
Bayer AG (DEU) |
Bayer, spol. s.r.o. (SVK)
|
36227 |
- |
Áno
|
zobraziť
|
|
Ofev 100 mg mäkké kapsuly
cps mol (blis.Al/Al-perf.) 1x60 ks
|
|
HLL01EX09 - Nintedanib
|
CPS MOL |
Boehringer Ingelheim International GmbH (DEU) |
Boehringer Ingelheim RCV GmbH & Co KG, org. Zložka (SVK)
|
3083B |
5/2015 |
Áno
|
zobraziť
|
|
Ofev 150 mg mäkké kapsuly
cps mol (blis.Al/Al-perf.) 1x60 ks
|
|
HLL01EX09 - Nintedanib
|
CPS MOL |
Boehringer Ingelheim International GmbH (DEU) |
Boehringer Ingelheim RCV GmbH & Co KG, org. Zložka (SVK)
|
3085B |
5/2015 |
Áno
|
zobraziť
|
|
Pazopanib Accord 200 mg
tbl flm (blis.PVC/PE/PVDC/Al) 1x90 ks
|
|
HLL01EX03 - Pazopanib
|
TBL FLM |
Accord Healthcare Polska Sp. z o.o. (POL) |
ProFound Bratislava, s.r.o. (SVK)
|
5805E |
10/2024 |
Áno
|
zobraziť
|
|
Pazopanib Accord 400 mg
tbl flm (fľ.HDPE) 1x30 ks
|
|
HLL01EX03 - Pazopanib
|
TBL FLM |
Accord Healthcare Polska Sp. z o.o. (POL) |
ProFound Bratislava, s.r.o. (SVK)
|
5800E |
10/2024 |
Áno
|
zobraziť
|
|
Pazopanib G.L. Pharma 200 mg
tbl flm (blis.Al/PVC/PE/PVDC) 1x90 ks
|
|
HLL01EX03 - Pazopanib
|
TBL FLM |
G.L.Pharma GmbH (AUT) |
G.L. Pharma Slovakia, s. r. o. (SVK)
|
0822E |
1/2023 |
Áno
|
zobraziť
|
|
Pazopanib G.L. Pharma 400 mg
tbl flm (blis.Al/PVC/PE/PVDC) 1x30 ks
|
|
HLL01EX03 - Pazopanib
|
TBL FLM |
G.L.Pharma GmbH (AUT) |
G.L. Pharma Slovakia, s. r. o. (SVK)
|
0666E |
1/2023 |
Áno
|
zobraziť
|
|
Pazopanib Gedeon Richter 200 mg
tbl flm (blis.Al/PVC/PE/PVDC) 1x90 ks
|
|
HLL01EX03 - Pazopanib
|
TBL FLM |
Gedeon Richter Plc. (HUN) |
Gedeon Richter Plc. (HUN)
|
9909D |
12/2022 |
Áno
|
zobraziť
|
|
Pazopanib Gedeon Richter 400 mg
tbl flm (blis.Al/PVC/PE/PVDC) 1x30 ks
|
|
HLL01EX03 - Pazopanib
|
TBL FLM |
Gedeon Richter Plc. (HUN) |
Gedeon Richter Plc. (HUN)
|
9916D |
12/2022 |
Áno
|
zobraziť
|
|
Pazopanib Glenmark 200 mg
tbl flm (blis.Al/PVC/PE/PVDC) 1x90 ks
|
|
HLL01EX03 - Pazopanib
|
TBL FLM |
Glenmark Pharmaceuticals s.r.o. (CZE) |
GLENMARK PHARMACEUTICALS SK, s.r.o. (SVK)
|
9694D |
7/2022 |
Áno
|
zobraziť
|
|
Pazopanib Glenmark 400 mg
tbl flm (blis.Al/PVC/PE/PVDC) 1x30 ks
|
|
HLL01EX03 - Pazopanib
|
TBL FLM |
Glenmark Pharmaceuticals s.r.o. (CZE) |
GLENMARK PHARMACEUTICALS SK, s.r.o. (SVK)
|
9699D |
7/2022 |
Áno
|
zobraziť
|
|
Pazopanib STADA 200 mg
tbl flm (blis.Al/PVC/PE/PVDC) 1x90 ks
|
|
HLL01EX03 - Pazopanib
|
TBL FLM |
STADA Pharma (DEU) |
STADA PHARMA Slovakia, s. r. o. (SVK)
|
0172E |
9/2022 |
Áno
|
zobraziť
|
|
Pazopanib STADA 400 mg
tbl flm (blis.Al/PVC/PE/PVDC) 1x30 ks
|
|
HLL01EX03 - Pazopanib
|
TBL FLM |
STADA Pharma (DEU) |
STADA PHARMA Slovakia, s. r. o. (SVK)
|
0181E |
9/2022 |
Áno
|
zobraziť
|
|
Pazopanib Teva 200 mg
tbl flm (blis.Al/PVC/PE/PVDC) 1x90 ks
|
|
HLL01EX03 - Pazopanib
|
TBL FLM |
Teva B.V. (NLD) |
TEVA Pharmaceuticals Slovakia s.r.o. (SVK)
|
9684D |
6/2022 |
Áno
|
zobraziť
|
|
Pazopanib Teva 400 mg
tbl flm (blis.Al/PVC/PE/PVDC) 1x30 ks
|
|
HLL01EX03 - Pazopanib
|
TBL FLM |
Teva B.V. (NLD) |
TEVA Pharmaceuticals Slovakia s.r.o. (SVK)
|
9686D |
6/2022 |
Áno
|
zobraziť
|
|
Pazopanib Zentiva 200 mg
tbl flm (blis.Al/PVC/PE/PVDC) 1x90 ks
|
|
HLL01EX03 - Pazopanib
|
TBL FLM |
Zentiva, k.s. (CZE) |
Zentiva International a.s. (SVK)
|
0153E |
8/2022 |
Áno
|
zobraziť
|
|
Pazopanib Zentiva 400 mg
tbl flm (blis.Al/PVC/PE/PVDC) 1x30 ks
|
|
HLL01EX03 - Pazopanib
|
TBL FLM |
Zentiva, k.s. (CZE) |
Zentiva International a.s. (SVK)
|
0160E |
8/2022 |
Áno
|
zobraziť
|
|
Retsevmo 40 mg
cps dur (blis.PCTFE/PVC/Al) 1x56 ks
|
|
HLL01EX22 - Selperkatinib
|
CPS DUR |
Eli Lilly Nederland B.V. (NLD) |
Eli Lilly ČR, s.r.o. (CZE)
|
8164D |
10/2022 |
Áno
|
zobraziť
|
|
Retsevmo 80 mg
cps dur (blis.PCTFE/PVC/Al) 1x112 ks
|
|
HLL01EX22 - Selperkatinib
|
CPS DUR |
Eli Lilly Nederland B.V. (NLD) |
Eli Lilly ČR, s.r.o. (CZE)
|
8169D |
10/2022 |
Áno
|
zobraziť
|
|
Rozlytrek 200 mg
cps dur (fľ.HDPE) 1x90 ks
|
|
HLL01EX14 - Entrektinib
|
CPS DUR |
Roche Registration GmbH (DEU) |
Roche Slovensko, s.r.o. (SVK)
|
5483D |
8/2021 |
Áno
|
zobraziť
|
|
Rydapt 25 mg mäkké kapsuly
cps mol (blis.PA/Al/PVC-Al) 1x56 ks
|
|
HLL01EX10 - Midostaurín
|
CPS MOL |
Novartis Europharm Limited (IRL) |
Novartis Slovakia s.r.o. (Divízia Pharma) (SVK)
|
7166C |
7/2018 |
Áno
|
zobraziť
|
|
Sorafenib Sandoz 400 mg
tbl flm (blis.Al/OPA/Al/PVC) 1x56 ks
|
|
HLL01EX02 - Sorafenib
|
TBL FLM |
Sandoz Pharmaceuticals d.d. (SVN) |
SANDOZ d.d. - organizačná zložka (SVK)
|
8654D |
2/2023 |
Áno
|
zobraziť
|
|
Sorafenib STADA 200 mg
tbl flm (blis.Al/PVC/PE/PVDC-jednotliv.dáv.) 112x1 ks
|
|
HLL01EX02 - Sorafenib
|
TBL FLM |
STADA Pharma (DEU) |
STADA PHARMA Slovakia, s. r. o. (SVK)
|
4980D |
9/2021 |
Áno
|
zobraziť
|
|
Sorafenib Teva 200 mg
tbl flm (blis.PVC/Aclar/PVC/Al) 1x112 ks
|
|
HLL01EX02 - Sorafenib
|
TBL FLM |
TEVA Pharmaceuticals Slovakia s.r.o. (SVK) |
TEVA Pharmaceuticals Slovakia s.r.o. (SVK)
|
0997D |
7/2021 |
Áno
|
zobraziť
|
|
Sorafenib Zentiva 200 mg
tbl flm (blis.Al/PVC/PE/PVDC-jednotliv.dáv.) 112x1 ks
|
|
HLL01EX02 - Sorafenib
|
TBL FLM |
Zentiva, k.s. (CZE) |
Zentiva International a.s. (SVK)
|
4974D |
7/2021 |
Áno
|
zobraziť
|
|
Stivarga 40 mg
tbl flm (fľ.HDPE) (3x28) 1x84 ks
|
|
HLL01EX05 - Regorafenib
|
TBL FLM |
Bayer AG (DEU) |
Bayer, spol. s.r.o. (SVK)
|
6959A |
9/2013 |
Áno
|
zobraziť
|
|
Sunitinib Accord 12,5 mg
cps dur (fľ.HDPE) 1x30 ks
|
|
HLL01EX01 - Sunitinib
|
CPS DUR |
Accord Healthcare S.L.U (ESP) |
ProFound Bratislava, s.r.o. (SVK)
|
7317D |
2/2022 |
Áno
|
zobraziť
|
|
Sunitinib Accord 25 mg
cps dur (fľ.HDPE) 1x30 ks
|
|
HLL01EX01 - Sunitinib
|
CPS DUR |
Accord Healthcare S.L.U (ESP) |
ProFound Bratislava, s.r.o. (SVK)
|
7320D |
2/2022 |
Áno
|
zobraziť
|
|
Sunitinib Accord 50 mg
cps dur (fľ.HDPE) 1x30 ks
|
|
HLL01EX01 - Sunitinib
|
CPS DUR |
Accord Healthcare S.L.U (ESP) |
ProFound Bratislava, s.r.o. (SVK)
|
7326D |
2/2022 |
Áno
|
zobraziť
|
|
Sunitinib G.L. Pharma 12,5 mg
cps dur (blis.Al/OPA/AL/PVC) 1x30 ks
|
|
HLL01EX01 - Sunitinib
|
CPS DUR |
G.L.Pharma GmbH (AUT) |
G.L. Pharma Slovakia, s. r. o. (SVK)
|
6606D |
3/2022 |
Áno
|
zobraziť
|
|
Sunitinib G.L. Pharma 25 mg
cps dur (blis.Al/OPA/Al/PVC) 1x30 ks
|
|
HLL01EX01 - Sunitinib
|
CPS DUR |
G.L.Pharma GmbH (AUT) |
G.L. Pharma Slovakia, s. r. o. (SVK)
|
6608D |
3/2022 |
Áno
|
zobraziť
|
|
Sunitinib G.L. Pharma 50 mg
cps dur (blis.Al/OPA/Al/PVC) 1x30 ks
|
|
HLL01EX01 - Sunitinib
|
CPS DUR |
G.L.Pharma GmbH (AUT) |
G.L. Pharma Slovakia, s. r. o. (SVK)
|
6610D |
3/2022 |
Áno
|
zobraziť
|
|
Sunitinib Glenmark 12,5 mg
cps dur (fľ.HDPE) 1x30 ks
|
|
HLL01EX01 - Sunitinib
|
CPS DUR |
Glenmark Pharmaceuticals s.r.o. (CZE) |
GLENMARK PHARMACEUTICALS SK, s.r.o. (SVK)
|
7971D |
2/2022 |
Áno
|
zobraziť
|
|
Sunitinib Glenmark 25 mg
cps dur (fľ.HDPE) 1x30 ks
|
|
HLL01EX01 - Sunitinib
|
CPS DUR |
Glenmark Pharmaceuticals s.r.o. (CZE) |
GLENMARK PHARMACEUTICALS SK, s.r.o. (SVK)
|
7973D |
2/2022 |
Áno
|
zobraziť
|
|
Sunitinib Glenmark 50 mg
cps dur (fľ.HDPE) 1x30 ks
|
|
HLL01EX01 - Sunitinib
|
CPS DUR |
Glenmark Pharmaceuticals s.r.o. (CZE) |
GLENMARK PHARMACEUTICALS SK, s.r.o. (SVK)
|
7977D |
2/2022 |
Áno
|
zobraziť
|
|
Sunitinib Krka 12,5 mg tvrdé kapsuly
cps dur (blis.OPA/Al/PE/Al-jednotliv.dáv.) 30x1 ks
|
|
HLL01EX01 - Sunitinib
|
CPS DUR |
KRKA, d.d., Novo Mesto (SVN) |
-
|
7807D |
2/2022 |
Nie
|
zobraziť
|
|
Sunitinib Krka 25 mg tvrdé kapsuly
cps dur (blis.OPA/Al/PE/Al-jednotliv.dáv.) 30x1 ks
|
|
HLL01EX01 - Sunitinib
|
CPS DUR |
KRKA, d.d., Novo Mesto (SVN) |
-
|
7815D |
1/2022 |
Nie
|
zobraziť
|
|
Sunitinib Krka 50 mg tvrdé kapsuly
cps dur (blis.OPA/Al/PE/Al-jednotliv.dáv.) 30x1 ks
|
|
HLL01EX01 - Sunitinib
|
CPS DUR |
KRKA, d.d., Novo Mesto (SVN) |
-
|
7823D |
2/2022 |
Nie
|
zobraziť
|
|
Sunitinib Pharmagen 12,5 mg
cps dur (fľ.HDPE) 1x30 ks
|
|
HLL01EX01 - Sunitinib
|
CPS DUR |
PHARMAGEN CZ s.r.o. (CZE) |
PHARMAGEN CZ s.r.o. (CZE)
|
7789D |
6/2022 |
Áno
|
zobraziť
|